A
Aeglea Biotherapeutics (AGLE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aeglea Biotherapeutics (AGLE)
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 tha... Read more
- USD11.34
- USD12.31
- USD11.01
- USD39.00
- -11.10%
- 1M
- 14.48k
- 50.25k
- 48M
- 2.66
- 5.40%
Stock News
44 minutes ago
Dow Jones Futures: Market Correction Intensifies, S&P 500 Nears Key Level; Meta AI Push In Focus
Yahoo
47 minutes ago
: Fed rate cuts could come sooner than expected, says former Goldman CEO Lloyd Blankfein
MarketWatch
yesterday
The Ratings Game: Could a break-up of Amazon be good for the stock? Analysts weigh in after FTC lawsuit.
MarketWatch
yesterday
Cramer says Amazon and Google stocks are still buys, despite antitrust lawsuits
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
